Global Blood Therapeutics Employee Directory
Biotechnology ResearchCalifornia, United States51-200 Employees
Global Blood Therapeutics is a mid-sized biotechnology company based in South San Francisco, California, focused on developing therapies for blood disorders with a primary emphasis on sickle cell disease. The organization aims to address unmet needs of underserved patient communities and pursues next-generation approaches to treating SCD. It operates within the biotechnology research industry, building a portfolio intended to expand treatment options for blood-related conditions. In 2022, Global Blood Therapeutics became part of Pfizer, and its standalone public page is no longer actively monitored, with updates now issued through Pfizer channels. The company remains anchored in South San Francisco and continues its research and development activities within the broader pharmaceutical enterprise.